Immunotherapy
Comments
-
Good luck with your treatment tomorrow! My childhood friend, who I mentioned in Post #13 above, completed three years on Keytruda. She was diagnosed with endometrial cancer (stage 4, grade 3), in early 2017. She started on Ketruda and Lenvima in 2020, after Keytruda was approved for endometrial cancer. The Lenvima was subsequently discontinued due to side effects and she continued on Keytruda alone for another two years. Her last several CT scans showed no evidence of disease and she finished treatment in June 2023. Her daughter and granddaughter threw her a wonderful surprise party in July to celebrate her NED status and the completion of six continuous years of endometrial cancer treatment.
Hoping for similar results for you!
2
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 718 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards